Search

Author/Creator Groshen, Susan G.

1. P53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression: A Single Institutional Clinicopathologic Study. Issue 4 (1st April 2014)

Authors:
Xie, Yi; Bulbul, Mohmad Ajaz; Ji, Lingyun; Inouye, Casey M.; Groshen, Susan G.; Tulpule, Anil; O'Malley, Dennis P.; Wang, Endi; Siddiqi, Imran N.
Journal:
American journal of clinical pathology
Issue:
Volume 141:Issue 4(2014)
Page Start:
593
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression: A Single Institutional Clinicopathologic Study. Issue 4 (1st April 2014)

Authors:
Xie, Yi; Bulbul, Mohmad Ajaz; Ji, Lingyun; Inouye, Casey M.; Groshen, Susan G.; Tulpule, Anil; O'Malley, Dennis P.; Wang, Endi; Siddiqi, Imran N.
Journal:
American journal of clinical pathology
Issue:
Volume 141:Issue 4(2014)
Page Start:
593
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial. Issue 7 (30th March 2018)

Authors:
Pinto, Navin; DuBois, Steven G.; Marachelian, Araz; Diede, Scott J.; Taraseviciute, Agne; Glade Bender, Julia L.; Tsao‐Wei, Denice; Groshen, Susan G.; Reid, Joel M.; Haas‐Kogan, Daphne A.; Reynolds, C. Patrick; Kang, Min H.; Irwin, Meredith S.; Macy, Margaret E.; Villablanca, Judith G.; Matthay, ...
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 7(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗